On April 11, 2022, Sherilyn McCoy, a Director of NovoCure Limited since 2018, notified the Company of her intention not to stand for reelection to the Board of Directors of the Company at the Company's 2022 annual general meeting of shareholders, which is currently scheduled for June 8, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.34 USD | +2.36% | +2.41% | -17.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.35% | 1.33B | |
+72.58% | 12.34B | |
-18.04% | 7.98B | |
+3.57% | 5.81B | |
+6.65% | 5.04B | |
+20.83% | 4.31B | |
-20.22% | 4.03B | |
-41.19% | 2.21B | |
+0.25% | 1.99B | |
+4.02% | 1.87B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Novocure Limited Announces Resignation of Sherilyn McCoy from the Board of Directors